⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11685771 | 1.00 | — | — | |
| SCHEMBL296273 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL11684187 | 0.97 | ALDH1A1 (0.54) | — | |
| Valine SCHEMBL18301545 | 0.87 | SLC7A5 (0.62) | — | |
| Valine SCHEMBL18301544 | 0.87 | SLC7A5 (0.62) | — | |
| SCHEMBL13227969 | 0.83 | — | — | |
| SCHEMBL5299472 | 0.83 | — | — | |
| SCHEMBL23093886 | 0.79 | ALDH1A1 (0.52) | — | |
| SCHEMBL21688194 | 0.79 | ALDH1A1 (0.52) | — | |
| SCHEMBL18774926 | 0.79 | ALDH1A1 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 558 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116365044-A | Electrolyte, secondary battery and electric equipment | 欣旺达电动汽车电池有限公司 | 2023-06-30 | — | — | CN | claimed |
| US-11680088-B2 | Bioactive peptides derived from snakes | UNIVERSITEIT LEIDEN (NL) | 2023-06-20 | — | — | US | claimed |
| EP-2994154-B1 | ANTIMICROBIAL PEPTIDE | ACADEMISCH ZIEKENHUIS LEIDEN (NL) | 2020-02-26 | — | — | EP | claimed |
| US-20190016766-A1 | Use of improved modulators of complement function as cancer therapeutics | BENJAMIN DANIEL E (US) | 2019-01-17 | — | — | US | claimed |
| US-20180369328-A1 | Modulators of Complement Function | FRITZINGER DAVID C (US) | 2018-12-27 | — | — | US | claimed |
| US-10130677-B2 | Antimicrobial peptide and uses thereof | ACADEMISCH ZIEKENHUIS LEIDEN H.O.D.N. LUMC (NL) | 2018-11-20 | — | — | US | claimed |
| EP-3087092-B1 | ANTIMICROBIAL PEPTIDE AND USES THEREOF | ACADEMISCH ZIEKENHUIS LEIDEN (NL) | 2018-07-25 | — | — | EP | claimed |
| EP-3335720-A1 | C-DI-GMP BINDING PEPTIDES | Universität Basel (CH) | 2018-06-20 | — | — | EP | claimed |
| WO-2017060891-A1 | MODULATORS OF COMPLEMENT FUNCTION | FRITZINGER DAVID C (US) | 2017-04-13 | — | — | WO | claimed |
| US-20160317611-A1 | Antimicrobial Peptide and Uses Thereof | ACADEMISCH ZIEKENHUIS LEIDEN H.O.D.N. LUMC (NL) | 2016-11-03 | — | — | US | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| CN-116507617-B | 1- (2- (4-Cyclopropyl-1H-1, 2, 3-triazol-1-yl) acetyl) -4-hydroxypyrrolidine-2-carboxamide derivatives as VHL inhibitors | 基因泰克公司 | 2026-05-22 | — | — | CN | disclosed |
| US-20260001924-A1 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | NEW YORK UNIVERSITY (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250346639-A1 | BACTERIOCIN POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE THEREOF | SYNGULON SA (BE) | 2025-11-13 | — | — | US | disclosed |
| US-20250312303-A1 | ANTICANCER AGENT | AGC Inc. (JP) | 2025-10-09 | — | — | US | disclosed |
| US-5763474-A | SMOOTH MUSCLE RELAXANTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1998-06-09 | — | — | US | disclosed |
| WO-1998002413-A1 | SUBSTITUTED N-ARYLMETHYLAMINO DERIVATIVES OF CYCLOBUTENE-3,4-DIONES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1998-01-22 | — | — | WO | disclosed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | disclosed |
| EP-0787010-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-06 | — | — | EP | disclosed |
| WO-1996012499-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-05-02 | — | — | WO | disclosed |